Chiara Cremolini



Chiara Cremolini is Associated Professor in Medical Oncology at University of Pisa. In 2008 she obtained degree in Medicine, in 2011 a second-level Master in Drugs’ Development, in 2014 a specialization in Medical Oncology, in 2018 a PhD in Clinical Pathophysiology at the University of Pisa.
She is mainly committed to the clinical management of patients affected by gastrointestinal malignancies and is involved in clinical and translational research projects in the field of colorectal oncology. She actively contributes to clinical trials by the cooperative GONO group and, as a translational interest, she is especially involved in the identification of potential molecular predictors of benefit from systemic treatments. She has author and co-authored of 200 peer-reviewed publications regarding colorectal cancer and has received merit awards at different international meetings for her research activity.


Adverse events during first-line treatments for mCRC: The Toxicity over Time (ToxT) analysis of three randomised trials

Eur J Cancer. 2023 Aug;
doi: 10.1016/j.ejca.2023.05.001 – PubMed ID: 37301718